Epoch Investment Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $76.6M | Sell |
549,365
-47,960
| -8% | -$6.72M | 0.46% | 84 |
|
|
2025
Q4 | $73.3M | Sell |
597,325
-39,610
| -6% | -$4.81M | 0.42% | 94 |
|
|
2025
Q3 | $70.7M | Sell |
636,935
-221,339
| -26% | -$25.2M | 0.39% | 98 |
|
|
2025
Q2 | $95.2M | Buy |
858,274
+743,235
| +646% | +$79.1M | 0.49% | 74 |
|
|
2025
Q1 | $12.9M | Buy |
+115,039
| New | +$11.9M | 0.07% | 199 |
|
|
2024
Q4 | – | Sell |
-13,632
| Closed | -$1.14M | – | 325 |
|
|
2024
Q3 | $1.14M | Sell |
13,632
-1,992
| -13% | -$152K | 0.01% | 294 |
|
|
2024
Q2 | $1.07M | Sell |
15,624
-872,354
| -98% | -$58.2M | ﹤0.01% | 305 |
|
|
2024
Q1 | $65M | Buy |
887,978
+139,907
| +19% | +$10.8M | 0.29% | 122 |
|
|
2023
Q4 | $60.6M | Buy |
748,071
+247,652
| +49% | +$19.3M | 0.28% | 139 |
|
|
2023
Q3 | $37.5M | Sell |
500,419
-52,093
| -9% | -$4.01M | 0.24% | 142 |
|
|
2023
Q2 | $42.6M | Sell |
552,512
-20,149
| -4% | -$1.61M | 0.25% | 144 |
|
|
2023
Q1 | $47.5M | Sell |
572,661
-293,278
| -34% | -$24.3M | 0.28% | 123 |
|
|
2022
Q4 | $74.3M | Sell |
865,939
-32,217
| -4% | -$2.55M | 0.44% | 75 |
|
|
2022
Q3 | $55.4M | Sell |
898,156
-23,476
| -3% | -$1.48M | 0.36% | 97 |
|
|
2022
Q2 | $57M | Buy |
921,632
+96,437
| +12% | +$5.97M | 0.33% | 105 |
|
|
2022
Q1 | $49.1M | Buy |
825,195
+116,195
| +16% | +$7.43M | 0.24% | 135 |
|
|
2021
Q4 | $51.5M | Buy |
709,000
+123,883
| +21% | +$8.53M | 0.26% | 137 |
|
|
2021
Q3 | $40.9M | Sell |
585,117
-15,013
| -3% | -$1.05M | 0.23% | 135 |
|
|
2021
Q2 | $41.3M | Buy |
+600,130
| New | +$40.1M | 0.22% | 137 |
|
|
2018
Q1 | – | Sell |
-27,545
| Closed | -$1.97M | – | 318 |
|
|
2017
Q4 | $1.97M | Sell |
27,545
-108
| -0.4% | -$8.2K | 0.01% | 273 |
|
|
2017
Q3 | $2.24M | Hold |
27,653
| – | – | 0.01% | 271 |
|
|
2017
Q2 | $1.96M | Buy |
27,653
+20,473
| +285% | +$1.36M | 0.01% | 273 |
|
|
2017
Q1 | $488K | Buy |
+7,180
| New | +$505K | ﹤0.01% | 306 |
|
|
2016
Q3 | – | Sell |
-4,340,442
| Closed | -$362M | – | 293 |
|
|
2016
Q2 | $362M | Sell |
4,340,442
-479,860
| -10% | -$42.6M | 1.36% | 21 |
|
|
2016
Q1 | $443M | Buy |
4,820,302
+580,832
| +14% | +$52.4M | 1.67% | 10 |
|
|
2015
Q4 | $429M | Sell |
4,239,470
-118,038
| -3% | -$12.3M | 1.7% | 12 |
|
|
2015
Q3 | $428M | Buy |
4,357,508
+1,534,399
| +54% | +$170M | 1.66% | 10 |
|
|
2015
Q2 | $331M | Buy |
2,823,109
+2,815,544
| +37,218% | +$308M | 1.22% | 19 |
|
|
2015
Q1 | $742K | Buy |
+7,565
| New | +$768K | ﹤0.01% | 243 |
|
Other funds holding GILD
VCM
VPM
Epoch Investment Partners's GILD Position: Q1 2026 in Review
Epoch Investment Partners reduced its Gilead Sciences (GILD) stake by 8% in Q1 2026, selling an estimated $6.72M and leaving 549,365 shares worth $76.6M. The position accounts for 0.46% of the portfolio, ranked #84.
Epoch Investment Partners first reported a position in GILD in Q1 2015 and has held it in 29 quarters since. The position peaked at $443M in Q1 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Epoch Investment Partners held 549,365 shares of Gilead Sciences worth $76.6M as of Q1 2026.
- Epoch Investment Partners sold 47,960 Gilead Sciences shares in Q1 2026, an estimated $6.72M.
- Gilead Sciences made up 0.46% of Epoch Investment Partners's portfolio in Q1 2026, its #84 holding.
- Epoch Investment Partners first reported a position in Gilead Sciences in Q1 2015 and has held it in 29 quarters since.
- Epoch Investment Partners's Gilead Sciences position peaked at $443M in Q1 2016.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Epoch Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.